News & Perspective

Sep 27, 2019

Sep 27, 2019

ASP Scan (Weekly) for Sep 27, 2019

Molecular test for blood infections
Rapid TB test assessment
CRE risk in Europe
Cefto-tazo for nosocomial pneumonia
XDR typhoid in Taiwan
UK antimicrobial resistance funds
CARB-X diagnostic graduate
Outpatient antibiotic prescribing
Hospital Candida auris outbreak
AMR Challenge commitments
UK prescribing letter

Sep 23, 2019

Sep 23, 2019

Stewardship / Resistance Scan for Sep 23, 2019

AMR Challenge commitments
UK prescribing letter

Mar 08, 2019

Mar 08, 2019

ASP Scan (Weekly) for Mar 08, 2019

Home therapy for kids' cellulitis
Antibiotics and UTI relapse
Outpatient surgery overprescribing
Resistance prevalence and sepsis
Resistant gonorrhea strain
Empiric antibiotics and UTI
Surgery-linked resistant Pseudomonas
Preventing healthcare-related infection
Resistance and sustainable development
New CARB-X funding
ESBL prediction models

Nov 16, 2018

Nov 16, 2018

ASP Scan (Weekly) for Nov 16, 2018

Improper prescribing in the ER
Hospital stewardship in China
Antibiotic use in Poland
Swiss AMR-related illness, deaths
Antibiotic use in Scotland
Drug-resistant malaria in India
Spread of resistant bacteria in hospitals
Health departments against antimicrobial resistance
Public concern over antibiotic resistance

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

May 27, 2009

May 27, 2009

CDC releases viruses for novel H1N1 vaccine development

(CIDRAP News) – Sanofi Pasteur announced today that it has received a novel H1N1 influenza vaccine virus from the Centers for Disease Control and Prevention (CDC), moving the company a step closer to starting production of a vaccine.

CDC spokesman Tom Skinner said this afternoon that the agency is also sending the vaccine virus to other manufacturers, located overseas, who should receive the samples within a few days.

Jan 23, 2008

Jan 23, 2008

GAO cites barriers to antiviral, vaccine roles in pandemic

(CIDRAP News) – Antiviral medications and vaccines are two tools that many government and health officials hope will stall the spread of an influenza pandemic, but each strategy has daunting challenges, according to a new report from Congress's Government Accountability Office (GAO).

May 16, 2007

May 16, 2007

Syndromic surveillance: faulty alarm system or useful tool?

(CIDRAP News) – At first glance, the Web page looks like an overhead shot of a fantastic game board: a map—identifiably Los Angeles—sprinkled with faceted roundels in a half-dozen colors.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»